MedPath

A randomized control trial of fluorescence cystoscopy-assisted en bloc transurethral resection and conventional transurethral resection in patients with non-muscle invasive bladder cancer

Phase 3
Recruiting
Conditions
on-muscle invasive bladder cancer
Registration Number
JPRN-UMIN000041273
Lead Sponsor
ara Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

1) Suspected of having carcinoma in situ (CIS) 2) History of allergic reaction to 5-aminolevulinic acid 3) Patients with clinically significant liver dysfucntion and liver inflammation 4) Patients with porphyria 5) Patients who can not agree with enrollment of the study by his/her own intention 6) Inappropriate for the enrolment by the judgement of the physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Two-year recurrence-free rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath